/policies/,/policies/clinical/,/policies/clinical/uwmf-clinical/,/policies/clinical/uwmf-clinical/uwmf-wide/,/policies/clinical/uwmf-clinical/uwmf-wide/clinical-policies-and-procedures/,/policies/clinical/uwmf-clinical/uwmf-wide/clinical-policies-and-procedures/medications-drug-specific/,

/policies/clinical/uwmf-clinical/uwmf-wide/clinical-policies-and-procedures/medications-drug-specific/102076.policy

201411307

page

100

UWMF,

Policies,Clinical,UWMF Clinical,UWMF-wide,Clinical Policies and Procedures,Medications, Drug-Specific

Boniva Administration (Intravenous Bolus) (102.076)

Boniva Administration (Intravenous Bolus) (102.076) - Policies, Clinical, UWMF Clinical, UWMF-wide, Clinical Policies and Procedures, Medications, Drug-Specific

102.076

1
UNIVERSITY OF WISCONSIN MEDICAL FOUNDATION
CLINICAL POLICY AND PROCEDURE

TITLE: Boniva Administration (Intravenous Bolus)

Effective Date: August, 2007 Approval: See Authorization
Supersedes Protocol: None Contact: Clinical Staff Education

Reviewed May 2009 August 2011


PURPOSE: To provide guidelines for administration of Boniva / Ibandronate (IV bolus)
at UWMF Clinics.

DEFINITION: Boniva /Ibandronate alters the cycle of bone formation and breakdown
in the body. Ibandronate is used to treat or prevent osteoporosis in women after
menopause.

POLICY: The clinical staff will utilize the following guidelines to properly administer
Boniva to UWMF patients.

SUPPLIES: Provider’s order, Patient’s record, Labeled syringe with appropriate drug
dose, Non-sterile gloves, IV start kit, Pressure dressing, 5mL NS

PROCEDURE:

1. Check the name and dose of medication against the provider’s order. Clarify any
inconsistencies.

2. Complete patient assessment and lab findings relevant to medication.
Obtain a serum Creatinine prior to administration of Boniva/ Ibandronate.
NOTE: If Creatinine is <0.8 or >1.4 contact provider.
Obtain patient’s vital signs.
Review patient’s drug allergies

3. Review medication order, adhering to the five rights of drug administration.
Right – drug, dose, time, route, patient
Check the expiration date of the medication

4. Identify the patient and provide privacy for the procedure.

5. Wash hands and apply gloves.

6. Start IV, obtaining a positive blood return.


2
7. Secure the IV in place.

8. Administer 3 mL Boniva over 15-30 seconds.

9. Flush IV with 5 mL of Normal Saline.

10. Remove IV and apply a pressure dressing.

11. Allow the patient to remain in the waiting room for 20-30 minutes to observe for any
adverse reactions.

12. In the patient’s record document the following:
Lab results
Vital signs
Date, drug name, dose, time
IV procedure – IV site, catheter size and fluid used and infused
Saline flush amount
Lot number, manufacturer, NDC# and expiration date
Educational instructions given to patient
How the patient tolerated the procedure
Follow-up care or appointment (if needed)



REVISED BY: LaVay Morrison RN Clinical Staff Educator
REVIEWED BY: Jody Lease, RN Case Manager Rheumatology
WRITTEN BY: Danielle Varnell, RN Clinical Staff Educator


REFERENCES: Eprocrates

AUTHORIZATION:



Medical Director Date